New lab-on-a-chip infection test could provide cheaper, faster portable diagnostics
(Imperial College London) A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

Differences in immunity and blood vessels likely protect children from severe COVID-19
(Murdoch Childrens Research Institute) Differences in the immune systems and better blood vessel health were among the factors protecting children from severe COVID-19, according to a new review. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

Researchers determine how the SARS-CoV-2 virus hijacks and rapidly causes damage to human lung cells
(Boston University School of Medicine) In a multi-group collaborative involving the National Emerging Infectious Disease Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), and the Center for Network Systems Biology (CNSB), scientists have reported the first map of the molecular responses of human lung cells to infection by SARS-CoV-2. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

Cell membranes in super resolution
(University of W ü rzburg) For the first time ever, expansion microscopy allows the imaging of even the finest details of cell membranes. This offers new insights into bacterial and viral infection processes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

Research reveals how a fungal infection activates inflammation
(St. Jude Children's Research Hospital) Scientists at St. Jude Children's Research Hospital have shed light on the mechanisms that underlie how Aspergillus fumigatus activates the inflammasome, with implications for therapeutic development. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

People returning home from skilled nursing facilities need tailored instructions
(Regenstrief Institute) Transitions from a skilled nursing facility to home are burdensome to already vulnerable individuals and are points in time where errors and gaps in care are more likely. COVID-19 has exacerbated transitional challenges, which can affect quality of life and cause the patient to lose progress made during their stay at a care facility. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

Kidney disease leading risk factor for COVID-related hospitalization
(Geisinger Health System) An analysis of Geisinger's electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

Amphibian die-offs worsened malaria outbreaks in Central America
(American Geophysical Union) The global collapse of frogs and other amphibians due to the amphibian chytrid fungus exacerbated malaria outbreaks in Costa Rica and Panama during the 1990s and 2000s, according to new research. The findings provide the first evidence that amphibian population declines have directly affected human health and show how preserving biodiversity can benefit humans as well as local ecosystems. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

CUNY SPH launches CONVINCE USA to understand and address public concerns about COVID vaccine
(CUNY Graduate School of Public Health and Health Policy) The City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) today launched CONVINCE USA, part of a global project to increase understanding of factors that influence people's willingness to accept new COVID-19 vaccines, and to promote inclusive public dialogue to reduce vaccine hesitancy. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2020 Category: Infectious Diseases Source Type: news

Targets for avoidable sight loss 'not being met': 30-year study finds
(University of Melbourne) A new global study has found no significant reduction in the number of people with treatable sight loss since 2010. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 1, 2020 Category: Infectious Diseases Source Type: news

Post-COVID pain or weakness? Request an ultrasound or MRI
(Northwestern University) A new Northwestern Medicine study shows how advanced imaging technology can pinpoint what may have caused patients' nerve damage and help determine the best course of treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 1, 2020 Category: Infectious Diseases Source Type: news

Out of many COVID-19 tests, which one to choose?
(American Institute of Physics) Curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined. However, the current diagnostic techniques vary in reliability and relevance, so an understanding of which test is most appropriate for a given circumstance is necessary to avoid false reports. Researchers evaluated the available diagnostic techniques and determined key steps required for better testing moving forward. They present their findings in the journal APL Bioengineering. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 1, 2020 Category: Infectious Diseases Source Type: news

KU Leuven vaccine candidate protects against Covid-19 and yellow fever
(KU Leuven) KU Leuven researchers published results of their vaccine candidate, a vector vaccine based on the yellow fever vaccine. The paper shows that the vaccine protects hamsters from infection with the SARS-CoV-2 coronavirus after a single dose. It is also effective in monkeys. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 1, 2020 Category: Infectious Diseases Source Type: news

Story tips from Johns Hopkins experts on Covid-19
(Johns Hopkins Medicine) Story tips from Johns Hopkins experts on Covid-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 1, 2020 Category: Infectious Diseases Source Type: news

Alcohol-free hand sanitizer just as effective against COVID as alcohol-based versions
(Brigham Young University) A new study from researchers at Brigham Young University finds that alcohol-free hand sanitizer is just as effective at disinfecting surfaces from the COVID-19 virus as alcohol-based products. In most of the test cases, the compounds found in alcohol-free sanitizers wiped out at least 99.9% of the virus within 15 seconds. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 1, 2020 Category: Infectious Diseases Source Type: news

COVID-19 researchers recognized with 2020 Golden Goose Award for scientific contributions
(American Association for the Advancement of Science) The ninth annual Golden Goose Award ceremony on December 1, 2020 will recognize three teams of scientists whose research has greatly benefited society. Led by the American Association for the Advancement of Science (AAAS), the award committee includes a bipartisan group of Congressional supporters and several science and higher education organizations. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 1, 2020 Category: Infectious Diseases Source Type: news

Repurposed mouse model sheds light on loss of smell in COVID-19
(University of Iowa Health Care) A repurposed mouse model can develop symptoms of both severe COVID-19 (lung damage, blood clots, abnormal blood vessels, and death) and also of milder disease, including loss of the sense of smell, according to a recent University of Iowa study published in Nature. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 1, 2020 Category: Infectious Diseases Source Type: news

COVID-19 news from Annals of Internal Medicine
(American College of Physicians) Black and Hispanic populations in the US experiencing disproportionately higher rates of COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

IVI, ROK's GDEF join forces to provide OCV to 540K people at risk of cholera in Nepal & Mozambique
(International Vaccine Institute) The International Vaccine Institute (IVI) and the Republic of Korea's Global Disease Eradication Fund (GDEF) have agreed to conduct joint projects to fight cholera, which include vaccination for a total of approximately 540,000 people at risk of cholera in Nepal and Mozambique. KOICA GDEF is providing a grant of US $8.05 million to support the project entitled 'Enhancing Cholera Control' (ECHO). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

COVID-19 Peer Hub combats vaccine avoidance amid pandemic
(University of South Australia) UniSA researchers are evaluating a new vaccination education initiative - the COVID-19 Peer Hub - to help immunisation and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Cancer survivors at higher risk of hospitalization or dying from flu
(London School of Hygiene& Tropical Medicine) Survivors from a wide range of cancers are more likely than people in the general population to be hospitalised or die from seasonal influenza even several years after their cancer diagnosis, according to new data published in EClinicalMedicine. Given that flu and COVID-19 are both epidemic respiratory viruses with broadly similar risk factors, the findings suggest that cancer survivors are also likely to be at raised risk of severe COVID-19 outcomes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

More than one-third of children with COVID-19 show no symptoms: study
(University of Alberta Faculty of Medicine& Dentistry) More than one-third of kids who have COVID-19 aren't showing symptoms, according to a University of Alberta study that suggests youngsters diagnosed with the disease may represent just a fraction of those infected. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

IPM's dapivirine ring for women's HIV prevention receives WHO prequalification
(International Partnership for Microbicides (IPM)) The nonprofit International Partnership for Microbicides (IPM) is pleased to announce the World Health Organization's (WHO) prequalification of the dapivirine ring, a monthly vaginal ring to reduce women's HIV risk. This designation from the WHO confirms that the ring meets global standards for quality, safety and efficacy. The product's addition to the WHO's list of prequalified medicines will help guide national and global procurement decisions, pending country regulatory approvals for its use. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Young people feel let down by politicians and media stereotypes, says new research
(University of Huddersfield) An international study titled: To Lockdown and back: young people's lived experience of the COVID-19 pandemic says young people's perspectives on COVID-19 recovery is being overshadowed by negative 'victim or villain' narratives. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Race/ethnicity among children with COVID-19-associated multisystem inflammatory syndrome
(JAMA Network) The distribution of race/ethnicity among cases of COVID-19]-associated multisystem inflammatory syndrome in children reported to the New York City Department of Health and Mental Hygiene is described in this observational study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Unemployment insurance, health-related social needs, health care access, mental health during COVID-19 pandemic
(JAMA Network) This observational study assessed whether receiving unemployment insurance is associated with lower health-related social needs, better health care access and better mental health during the COVID-19 pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Marinomed announces trial of Carragelose in COVID-19 at Swansea University Medical School
(MC Services AG) Marinomed Biotech AG announces clinical trial at Swansea University Medical School to investigate efficacy of Carragelose in preventing COVID-19 infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

How 'smell training' could help overcome post-viral smell distortions
(University of East Anglia) Smell loss is a prominent symptom of Covid-19 and the pandemic is leaving many people with long-term smell loss or smell distortions such as parosmia.Parosmia happens when people experience strange and often unpleasant smell distortions. Instead of smelling lemon you may smell petrol. New research shows that parosmia is associated with a recovery of smell performance among patients who undergo 'smell training' (sniffing at least four different odours twice a day every day for several months). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

How SARS-CoV-2 reaches the brain
(Charit é - Universit ä tsmedizin Berlin) Using post-mortem tissue samples, researchers from Charit é - Universit ä tsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19. The results show that SARS-CoV-2 enters the brain via nerve cells in the olfactory mucosa. For the first time, researchers have been able to produce electron microscope images of intact coronavirus particles inside the olfactory mucosa. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Wuhan mass screening identifies hundreds of asymptomatic cases
(University of East Anglia) A mass screening programme of 10 million Wuhan residents identified 300 asymptomatic cases in May, but none were infectious - according to a new study.They found no 'viable' virus in the asymptomatic cases and the close contacts of these positive asymptomatic cases did not test positive.But these findings do not show that the virus can't be passed on by asymptomatic carriers. Rather mask-wearing, hand washing, social distancing and lockdown have helped reduce Covid-19 virulence. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Recent updates on antimicrobial therapy
(Bentham Science Publishers) This book provides updates on the most recent studies about anti-infective agents, their mechanism of action, the relevant molecular targets and their implication in the development of novel antibiotics that have properties similar to their corresponding compounds of natural origin. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Rutgers leading coronavirus therapeutic clinical trial
(Rutgers University) Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Harvard's Wyss Institute licenses its eRapid technology to The iQ Group Global
(Wyss Institute for Biologically Inspired Engineering at Harvard) The Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its eRapid technology has been licensed to The iQ Group Global for COVID-19 diagnostic applications. The Australian consortium will integrate the biomarker detection technology with its transistor technology to enable specific and sensitive SARS-CoV-2 testing in addressing the global diagnostic gap in the rampant coronavirus pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

HIV-like virus edited out of primate genome
(Temple University Health System) Taking a major step forward in HIV research, scientists at the Lewis Katz School of Medicine at Temple University have successfully edited SIV - a virus closely related to HIV, the cause of AIDS - from the genomes of non-human primates. The breakthrough brings Temple researchers and their collaborators closer than ever to developing a cure for human HIV infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

New method identifies adaptive mutations in complex evolving populations
(University of California - Riverside) A team co-led by a scientist at the University of California, Riverside, has developed a method to study how HIV mutates to escape the immune system in multiple individuals, which could inform HIV vaccine design. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Experimental vaccine for deadly tickborne virus effective in cynomolgus macaques
(NIH/National Institute of Allergy and Infectious Diseases) An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health scientists. The study, published in Nature Microbiology, comes about three years after the same research group developed the macaque model for CCHFV. No specific treatments or vaccines for CCHFV exist. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Study tackles barriers to COVID-19 testing in Black communities
(Pennington Biomedical Research Center) Pennington Biomedical Research Center is leading a federally funded effort to increase COVID-19 testing in Louisiana's Black communities, which have been hit hard by the virus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Mechanism of action of chloroquine/hydroxychloroquine for COVID-19 infection
(Bentham Science Publishers) The recent serious outbreak of Covid19 has required urgent medical treatments for numerous patients. No clinically active vaccines or antiviral agents are available for Covid19. According to several studies, Chloroquine (CQ) and Hydroxychloroquine (HCQ) have shown promises as Covid19 antiviral especially when administered with Azithromycin (AZM). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

NIH announces restructured HIV clinical trials networks
(NIH/National Institute of Allergy and Infectious Diseases) The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced the clinical investigators and institutions that will lead four NIH HIV clinical trials networks over the next seven years to conduct the innovative, efficient clinical research needed to accelerate progress against the HIV pandemic. NIAID also awarded grants to 35 U.S. and international institutions selected as HIV clinical trials units (CTUs). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

UC San Diego selected to lead international HIV/AIDS clinical trials unit
(University of California - San Diego) University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

NIH re-funds ACTG for the next seven years
(University of California - Los Angeles Health Sciences) The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, has been re-funded for the next seven years by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and collaborating NIH Institutes. The group is led by Judith Currier, M.D., M.Sc, Professor of Medicine at UCLA, and Joseph Eron M.D., Professor of Medicine, University of North Carolina. The Operations Center is based at UCLA. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

COVID-19 studies should also focus on mucosal immunity, researchers argue
(University at Buffalo) More COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth, a new paper argues. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

ECDC and WHO call for improved HIV testing in Europe
(European Centre for Disease Prevention and Control (ECDC)) The number of people living with undiagnosed HIV is increasing in the WHO European Region. According to data published today by ECDC and the WHO/Europe, more than 136 000 people were newly diagnosed in 2019 - roughly 20% of these diagnoses were in the EU/EAA and 80% in the eastern part of the European Region. Every second HIV diagnosis (53%) happens at a late stage of the infection, when the immune system has already started to fail. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 26, 2020 Category: Infectious Diseases Source Type: news

Fiji's vaccine program reduces childhood death and illness: study
(University of Melbourne) Fiji's national vaccine program against pneumonia, a serious lung condition, and rotavirus, a common disease which causes severe diarrhoea and vomiting, has reduced illness and death, new research shows. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2020 Category: Infectious Diseases Source Type: news

SARS-CoV-2 mutations do not appear to increase transmissibility
(University College London) None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers, published in Nature Communications. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2020 Category: Infectious Diseases Source Type: news

Warwick scientists design model to predict cellular drug targets against COVID-19
This study helps understand how the virus uses the host to survive, and enable drug predictions for treating the virus to be made. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2020 Category: Infectious Diseases Source Type: news

Radboud university medical center research: Most lungs recover well after COVID-19
(Radboud University Medical Center) Lung tissue of patients who suffered severely from COVID-19 shows good recovery in most cases. This was revealed by a study carried out by the Radboud university medical center that has now been published in Clinical Infectious Diseases. A striking conclusion is that the group who was referred by a GP did not recover as well as patients who were admitted to the hospital's Intensive Care Unit (ICU). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2020 Category: Infectious Diseases Source Type: news

Effect of climate change on infectious diseases unknown to half of the population
(Universitat Autonoma de Barcelona) Although it is a widely known scientific fact that infectious diseases emerge and re-emerge due to climate change, a study which included the involvement of the UAB published in PlosOne reveals that 48.9% of the population surveyed are not aware of this relation. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2020 Category: Infectious Diseases Source Type: news

New study explains important cause of fatal influenza
(Karolinska Institutet) It is largely unknown why influenza infections lead to an increased risk of bacterial pneumonia. Researchers at Karolinska Institutet in Sweden have now described important findings leading to so-called superinfections, which claim many lives around the world every year. The study is published in the journalPNAS,Proceedings of the National Academy of Sciences, and can also contribute to research on COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2020 Category: Infectious Diseases Source Type: news

COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
(University of Alabama at Birmingham) A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama at Birmingham this spring and summer is poised for clinical testing to begin in December. Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2020 Category: Infectious Diseases Source Type: news